Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America.
PLoS One. 2012;7(1):e30672. doi: 10.1371/journal.pone.0030672. Epub 2012 Jan 25.
Prior studies of appetite regulatory networks, primarily in rodents, have established that targeted electrical stimulation of ventromedial hypothalamus (VMH) can alter food intake patterns and metabolic homeostasis. Consideration of this method for weight modulation in humans with severe overeating disorders and morbid obesity can be further advanced by modeling procedures and assessing endpoints that can provide preclinical data on efficacy and safety. In this study we adapted human deep brain stimulation (DBS) stereotactic methods and instrumentation to demonstrate in a large animal model the modulation of weight gain with VMH-DBS. Female Göttingen minipigs were used because of their dietary habits, physiologic characteristics, and brain structures that resemble those of primates. Further, these animals become obese on extra-feeding regimens. DBS electrodes were first bilaterally implanted into the VMH of the animals (n = 8) which were then maintained on a restricted food regimen for 1 mo following the surgery. The daily amount of food was then doubled for the next 2 mo in all animals to produce obesity associated with extra calorie intake, with half of the animals (n = 4) concurrently receiving continuous low frequency (50 Hz) VMH-DBS. Adverse motoric or behavioral effects were not observed subsequent to the surgical procedure or during the DBS period. Throughout this 2 mo DBS period, all animals consumed the doubled amount of daily food. However, the animals that had received VMH-DBS showed a cumulative weight gain (6.1±0.4 kg; mean ± SEM) that was lower than the nonstimulated VMH-DBS animals (9.4±1.3 kg; p<0.05), suggestive of a DBS-associated increase in metabolic rate. These results in a porcine obesity model demonstrate the efficacy and behavioral safety of a low frequency VMH-DBS application as a potential clinical strategy for modulation of body weight.
先前的食欲调节网络研究主要在啮齿动物中进行,这些研究已经确定,对腹内侧下丘脑(VMH)进行靶向电刺激可以改变食物摄入模式和代谢稳态。考虑到这种方法在严重暴饮暴食障碍和病态肥胖的人类中的体重调节作用,可以通过建模程序和评估终点来进一步推进,这些终点可以提供关于疗效和安全性的临床前数据。在这项研究中,我们适应了人类深部脑刺激(DBS)立体定向方法和仪器,在大型动物模型中证明了 VMH-DBS 对体重增加的调节作用。选择雌性哥廷根小型猪是因为它们的饮食习惯、生理特征和大脑结构与灵长类动物相似。此外,这些动物在额外喂食方案中会变得肥胖。首先将 DBS 电极双侧植入动物的 VMH(n=8),然后在手术后的 1 个月内维持限制饮食。在接下来的 2 个月中,所有动物的食物量都增加了一倍,以产生与额外热量摄入相关的肥胖,其中一半动物(n=4)同时接受连续低频(50 Hz)VMH-DBS。手术后或 DBS 期间没有观察到运动或行为不良反应。在整个 2 个月的 DBS 期间,所有动物都消耗了双倍的每日食物量。然而,接受 VMH-DBS 的动物的累积体重增加(6.1±0.4 kg;平均值±SEM)低于未接受刺激的 VMH-DBS 动物(9.4±1.3 kg;p<0.05),提示 DBS 相关的代谢率增加。这些在猪肥胖模型中的结果证明了低频 VMH-DBS 应用的疗效和行为安全性,作为一种潜在的临床策略,可以调节体重。